GlassScriptPhysician profile
Lavinia K Chong
NPI 1588779227
$12,389.37
in general payments reported to CMS, 2019-2025
15 companies · $216 in 2025
The $216 reported for 2025 was less than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $502 · 2020: $268 · 2021: $385 · 2022: $6,335 · 2023: $287 · 2024: $4,396 · 2025: $216.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,401 · Food and Beverage: $1,498.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,401.00 |
| Food and Beverage | $1,498.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Surgical Innovation Associates, INC. | $6,012.84 | 2022 | |
| Abbvie INC. | $3,401.00 | 2024 | |
| Mentor Worldwide LLC | $1,096.56 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Revance Therapeutics, INC. | $310.84 | 2024 | Daxxify |
| Galderma Laboratories, L.P. | $293.95 | 2019-2020 | |
| Acelrx Pharmaceuticals, INC. | $233.57 | 2020-2022 | |
| Polynovo North America LLC | $164.56 | 2024 | Novosorb Btm |
| Acera Surgical, INC. | $148.38 | 2024 | Restrata Wound Matrix |
| Tepha INC | $144.98 | 2019 | |
| Kerecis Limited | $144.64 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Lifenet Health | $132.40 | 2024 | Theragenesis Wound Matrix |
| Pacira Pharmaceuticals Incorporated | $131.04 | 2022 | |
| Biom'Up France Sas | $88.81 | 2021 | |
| Allergan, INC. | $68.98 | 2019-2021 | |
| Integra Lifesciences Corporation | $16.82 | 2023 | Durasorb Monofilament Mesh |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lavinia Chong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.